Acadian Asset Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,439
| Closed | -$23K | – | 1773 |
|
|
2024
Q1 | $23K | Buy |
+12,439
| New | +$23K | ﹤0.01% | 1472 |
|
|
2023
Q1 | – | Sell |
-37,167
| Closed | -$104K | – | 1782 |
|
|
2022
Q4 | $104K | Sell |
37,167
-26,067
| -41% | -$72.9K | ﹤0.01% | 1421 |
|
|
2022
Q3 | $139K | Buy |
+63,234
| New | +$139K | ﹤0.01% | 1288 |
|
|
2020
Q2 | – | Sell |
-30,049
| Closed | -$426K | – | 2246 |
|
|
2020
Q1 | $426K | Buy |
30,049
+21,176
| +239% | +$300K | ﹤0.01% | 1001 |
|
|
2019
Q4 | $141K | Buy |
+8,873
| New | +$141K | ﹤0.01% | 1372 |
|